A medical diagnostics startup that wants to use CRISPR technology to detect diseases just raised $23 million in venture funding

Mammoth Biosciences

• Mammoth Biosciences announced a $23 million funding round on Tuesday, setting the company up to try and make a dent in the $45 billion global disease detection market.
• The startup uses CRISPR-based technology to detect the presence of diseases like HPV and malaria in DNA from blood or urine samples. 
• The technology is easily transportable and doesn't require expensive machines to run tests.

---

Mammoth Biosciences' motto is simple: to make up-to-date diagnostics simple, accessible and affordable.

"If you think about what we're offering it's kind of like a pregnancy test," said Trevor Martin, co-founder and CEO of Mammoth Biosciences. But instead of tracking hormones that indicates whether a person is pregnant or not, it tracks the presence of diseases like HPV or malaria. 

See the rest of the story at Business Insider

NOW WATCH: Super-Earths are real and they could be an even better place for life than Earth

See Also:

• The former head of strategy at Allergan explains why he joined a startup that's bringing together 'two disparate but unstoppable trends'
• 8 tricks for doing the keto diet without driving yourself crazy
• DNA-testing company 23andMe has signed a $300 million deal with a drug giant. Here's how to delete your data if that freaks you out.

SEE ALSO: Meet the 29-year-old who founded a company that's using technology to find treatments for diseases thought to be incurable

from Feedburner https://ift.tt/2Oy24xJ